Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
hubergroup’s two newly added medical vans are dedicated to dental and eye care
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB
Essex enriches and complements Emmes’ services
Women of all ages will get round-the-clock access to comprehensive treatment
Integration of modern and traditional medicine to facilitate the illness to wellness journey
Subscribe To Our Newsletter & Stay Updated